All lobbying filings

CAPITOL COUNSEL LLC

CAPITOL COUNSEL LLC filed a Q3 report for MADRIGAL PHARMACEUTICALS, INC. on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · Biopharmaceutical company.

All filings by CAPITOL COUNSEL LLC · Everything MADRIGAL PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

FDA and regulatory issues related to the biopharmaceutical industry.

Medical/Disease Research/Clinical Labs

FDA and regulatory issues related to the biopharmaceutical industry.

Medicare/Medicaid

FDA and regulatory issues related to the biopharmaceutical industry, including CMMI Drug Pricing Models.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.